CN102220293B - 犬流感重组病毒及其制备方法和应用 - Google Patents

犬流感重组病毒及其制备方法和应用 Download PDF

Info

Publication number
CN102220293B
CN102220293B CN2011101395283A CN201110139528A CN102220293B CN 102220293 B CN102220293 B CN 102220293B CN 2011101395283 A CN2011101395283 A CN 2011101395283A CN 201110139528 A CN201110139528 A CN 201110139528A CN 102220293 B CN102220293 B CN 102220293B
Authority
CN
China
Prior art keywords
virus
gene
asn
ile
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2011101395283A
Other languages
English (en)
Chinese (zh)
Other versions
CN102220293A (zh
Inventor
李泽君
滕巧泱
张旭
周洁文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Veterinary Research Institute
Original Assignee
Shanghai Veterinary Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Veterinary Research Institute filed Critical Shanghai Veterinary Research Institute
Priority to CN2011101395283A priority Critical patent/CN102220293B/zh
Publication of CN102220293A publication Critical patent/CN102220293A/zh
Priority to PCT/CN2012/074722 priority patent/WO2012159522A1/zh
Priority to KR1020137031403A priority patent/KR20140031912A/ko
Priority to US14/119,366 priority patent/US20140286979A1/en
Priority to CA2837126A priority patent/CA2837126A1/en
Priority to EP12790131.2A priority patent/EP2716752A4/en
Priority to JP2014511717A priority patent/JP2014516530A/ja
Application granted granted Critical
Publication of CN102220293B publication Critical patent/CN102220293B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
CN2011101395283A 2011-05-26 2011-05-26 犬流感重组病毒及其制备方法和应用 Active CN102220293B (zh)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CN2011101395283A CN102220293B (zh) 2011-05-26 2011-05-26 犬流感重组病毒及其制备方法和应用
PCT/CN2012/074722 WO2012159522A1 (zh) 2011-05-26 2012-04-26 犬流感重组病毒及其制备方法和应用
KR1020137031403A KR20140031912A (ko) 2011-05-26 2012-04-26 개 인플루엔자 재조합 바이러스 및 그 제조방법과 응용
US14/119,366 US20140286979A1 (en) 2011-05-26 2012-04-26 Canine influenza recombinant virus, preparation method therefor and application thereof
CA2837126A CA2837126A1 (en) 2011-05-26 2012-04-26 Canine influenza recombinant virus, preparation method therefor and application thereof
EP12790131.2A EP2716752A4 (en) 2011-05-26 2012-04-26 RECOMBINANT DOG INFLUENZA VIRUS, MANUFACTURING METHOD AND APPLICATION THEREOF
JP2014511717A JP2014516530A (ja) 2011-05-26 2012-04-26 イヌインフルエンザ組み換えウイルス及びその製造方法、並びにその応用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011101395283A CN102220293B (zh) 2011-05-26 2011-05-26 犬流感重组病毒及其制备方法和应用

Publications (2)

Publication Number Publication Date
CN102220293A CN102220293A (zh) 2011-10-19
CN102220293B true CN102220293B (zh) 2012-12-19

Family

ID=44776999

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011101395283A Active CN102220293B (zh) 2011-05-26 2011-05-26 犬流感重组病毒及其制备方法和应用

Country Status (7)

Country Link
US (1) US20140286979A1 (enExample)
EP (1) EP2716752A4 (enExample)
JP (1) JP2014516530A (enExample)
KR (1) KR20140031912A (enExample)
CN (1) CN102220293B (enExample)
CA (1) CA2837126A1 (enExample)
WO (1) WO2012159522A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102220293B (zh) * 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用
CN103881983B (zh) * 2014-03-07 2016-08-31 中国农业科学院哈尔滨兽医研究所 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
KR101633489B1 (ko) 2015-02-25 2016-06-27 고패스 주식회사 통풍수단이 구비된 신발의 사출식 제조방법
NZ739260A (en) 2015-06-26 2019-09-27 Boehringer Ingelheim Animal Health Usa Inc Inactivated canine influenza vaccines and methods of making and uses thereof
CN105647877A (zh) * 2016-02-02 2016-06-08 南京农业大学 一株低毒力重组猪脑心肌炎病毒及其应用
CN107602697B (zh) * 2017-08-29 2020-05-05 杭州医学院 一种治疗流感嗜血杆菌引起鼻窦炎的血清及该血清的应用
CN113173976B (zh) * 2021-06-03 2022-07-12 北京市农林科学院 一种犬流感病毒h3亚型ha蛋白、其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101365482A (zh) * 2005-08-25 2009-02-11 梅瑞尔有限公司 犬流感疫苗
CN101801410A (zh) * 2007-09-10 2010-08-11 英特威国际有限公司 预防犬、猫和马流感传染的组合物和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1820853T3 (da) * 1999-04-06 2011-12-19 Wisconsin Alumni Res Found Rekombinant influenzavirus til vacciner og genterapi
CN1261564C (zh) * 2003-12-02 2006-06-28 中国农业科学院哈尔滨兽医研究所 人工重组的流感病毒及其应用
EP2407480B1 (en) * 2005-10-19 2014-07-16 University of Florida Research Foundation, Incorporated Materials for respiratory disease control in canines
KR100850545B1 (ko) * 2007-10-30 2008-08-05 주식회사 에니멀제네틱스 신규한 개 인플루엔자 바이러스 및 이의 백신
CN102220293B (zh) * 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101365482A (zh) * 2005-08-25 2009-02-11 梅瑞尔有限公司 犬流感疫苗
CN101801410A (zh) * 2007-09-10 2010-08-11 英特威国际有限公司 预防犬、猫和马流感传染的组合物和方法

Also Published As

Publication number Publication date
US20140286979A1 (en) 2014-09-25
JP2014516530A (ja) 2014-07-17
CN102220293A (zh) 2011-10-19
KR20140031912A (ko) 2014-03-13
EP2716752A4 (en) 2014-04-30
CA2837126A1 (en) 2012-11-29
EP2716752A1 (en) 2014-04-09
WO2012159522A1 (zh) 2012-11-29

Similar Documents

Publication Publication Date Title
Vincent et al. Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States
Choi et al. Genetic relationship of H3 subtype avian influenza viruses isolated from domestic ducks and wild birds in Korea and their pathogenic potential in chickens and ducks
JP2009297040A (ja) 低温適応性ウマインフルエンザウィルス
CN102220293A (zh) 犬流感重组病毒及其制备方法和应用
NO342494B1 (no) Isolert hunde-influensavirus A som er i stand til å infisere et hundedyr, isolert polynukleotid som omfatter en nukleotidsekvens og polynukleotid-ekspresjonskonstruksjon.
CN110680912B (zh) H3n2和h3n8亚型犬流感二价灭活苗及其制备方法与应用
Nogales et al. Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use
CN110305898A (zh) 哺乳动物细胞非易感h9n2亚型冷适应禽流感病毒的拯救
Ibrahim et al. A single dose of inactivated oil-emulsion bivalent H5N8/H5N1 vaccine protects chickens against the lethal challenge of both highly pathogenic avian influenza viruses
CN103328629A (zh) 针对大流行性甲型流感病毒h1n1的新型疫苗
CN106117369A (zh) 融合蛋白sHA1‑Fc及应用
Abdel Hamid et al. Pathogenicity of an Avian Influenza H9N2 Virus isolated From Broiler Chickens in Egypt.
CN104611299B (zh) 一种人工重组的h9n2禽流感病毒株、制备方法、疫苗组合物及其应用
Ren et al. Genotype-matched recombiant inactivated Newcastle disease virus vaccine confer protection against genotype Ⅻ challenge in geese with maternal antibodies
Li et al. Adaptation of a natural reassortant H5N2 avian influenza virus in mice
JP6682441B2 (ja) トリレオウイルスワクチン
CN102526718B (zh) 一种重组h5n1禽流感病毒细胞苗及应用
CN104073470A (zh) 一种h9n2亚型禽流感病毒的转瓶培养方法
Liang et al. Genetic and biological properties of H9N2 avian influenza viruses isolated in central China from 2020 to 2022
CN103937817A (zh) 鸡新城疫病毒yt毒株、其全基因组序列及其应用
Song et al. Assessing the efficacy of a recombinant H9N2 avian influenza virus–inactivated vaccine
Gao et al. The comparison of pathology in ferrets infected by H9N2 avian influenza viruses with different genomic features
CN102373181B (zh) 猪流感病毒和猪蓝耳病病毒混合病毒样颗粒、制备方法和应用
CN105087502B (zh) H9n2亚型禽流感病毒温度敏感性减毒活疫苗候选株ca‑28（ah）及其应用
CN105039270B (zh) H9n2亚型禽流感冷适应减毒株及其应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant